Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder
about
Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management.Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose TrialPractitioner review: Long-term pharmacological treatment of pediatric bipolar disorder.QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder.Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders.
P2860
Q34292768-CB2403C0-8B18-4A3A-B659-2FA3E8170CB2Q37246368-88562405-79C0-4D16-9180-3BDDFA6C77E7Q38218213-34A55BFC-7ADE-4B70-83B8-E26DB5B71051Q38244346-E76BF30A-70C2-46A2-8F90-FC68D296A373Q38284625-327B931D-C0F8-4DAB-815F-3A8CB9536028Q39285492-A1D7C6F4-99F9-4E8F-828D-4394BFC0F4AEQ52656684-08F929C6-5F21-40D1-9E2F-23DF299E2829Q55074589-B5C2E9E1-9F98-4292-81AC-14F23E829939
P2860
Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy, long-term safety, an ...... lescents with bipolar disorder
@en
Efficacy, long-term safety, an ...... escents with bipolar disorder.
@nl
type
label
Efficacy, long-term safety, an ...... lescents with bipolar disorder
@en
Efficacy, long-term safety, an ...... escents with bipolar disorder.
@nl
prefLabel
Efficacy, long-term safety, an ...... lescents with bipolar disorder
@en
Efficacy, long-term safety, an ...... escents with bipolar disorder.
@nl
P2093
P2860
P356
P1476
Efficacy, long-term safety, an ...... lescents with bipolar disorder
@en
P2093
Balarama K Gundapaneni
Douglas G Vanderburg
Elizabeth Pappadopulos
Idil Cavuş
Jeffrey H Schwartz
Melissa P DelBello
Robert L Findling
P2860
P304
P356
10.1089/CAP.2012.0029
P577
2013-10-10T00:00:00Z